EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding immunotherapy terminology: An analysis of provider‐patient conversations

Shannon Blee, Bari Rosenberg, Jeffrey M Switchenko, Rachel Hianik, Mary Catherine Thomson, Margie Dixon, Mehmet Asim Bilen, Rebecca D Pentz

ImmunoMedicine · 2021

DOI: 10.1002/imed.1028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoMedicine, 2021. Verfasst von Shannon Blee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Winship Cancer Institute, Emory University. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapy terminology is complex and can be difficult for patients to understand, threatening informed consent. The aims of this exploratory study are to determine whether patients understand immunotherapy terminology and if the provider defining the term improves patient understanding. Good patient/provider communication is important for good informed consent, patient adherence to treatment and patient outcomes.

Methods

Conversations between oncology providers and patients discussing immunotherapy were observed ( n = 39), and technical terms used were noted. With consent, patients were interviewed post‐conversation to assess their understanding of these terms ( n = 39). Comparisons of the terms were conducted using chi‐square tests, Fisher's exact tests, or ANOVA where appropriate. Results “Immunotherapy” was the most difficult for participants to understand with 48.7% (19/39) correctly defining immunotherapy. “Immunotherapy agents” was understood 53.8% (14/26) of the time. “Immune system” was well understood 88.5% (23/26). Providers defined immunotherapy in 97.4% of conversations. There was no correlation between having immunotherapy defined in the conversation, and the likelihood of a correct definition ( p = 0.487). “Immune system” was defined in 92.3% of conversations ( n = 26), and defining it in the conversation was correlated with increased patient understanding ( p = 0.009).

Conclusion

Our results indicate that patients have difficulty understanding some immunotherapy terminology. Since patient understanding of key terminology is crucial for informed consent and patient care, it is essential to implement interventions to improve understanding.

Schlagwörter

Stichwörter der Autor:innen

Immunotherapyimmunotherapy terminologyinformed consentpatient understandingpatient/provider communication

Autor:innen und Institutionen

  • Winship Cancer Institute, Emory University.
  • Duke University Medical Center, Emory University.
  • Rollins School of Public Health, Emory University.
  • UNC Chapel Hill School of Medicine.
  • Medical College of Georgia.
  • Emory University School of Medicine.

Förderung

  • NCI NIH HHS

Zitieren

APA

Blee, S., Rosenberg, B., Switchenko, J. M., Hianik, R., Thomson, M. C., Dixon, M., Bilen, M. A., & Pentz, R. D. (2021). Understanding immunotherapy terminology: An analysis of provider‐patient conversations. ImmunoMedicine. https://doi.org/10.1002/imed.1028

Vancouver

Blee S, Rosenberg B, Switchenko JM, Hianik R, Thomson MC, Dixon M, et al. Understanding immunotherapy terminology: An analysis of provider‐patient conversations. ImmunoMedicine. 2021. doi:10.1002/imed.1028

BibTeX
@article{Blee2021,
  author = {Blee, Shannon and Rosenberg, Bari and Switchenko, Jeffrey M and Hianik, Rachel and Thomson, Mary Catherine and Dixon, Margie and Bilen, Mehmet Asim and Pentz, Rebecca D},
  title = {Understanding immunotherapy terminology: An analysis of provider‐patient conversations},
  journal = {ImmunoMedicine},
  year = {2021},
  doi = {10.1002/imed.1028}
}
Kostenlos starten →